
























Duration of topical steroid application
after photorefractive keratectomy
with mitomycin C
Mojgan Pakbin, MSc, Mehdi Khabazkhoob, PhD, Mohammad Pakravan, MD,
Akbar Fotouhi, PhD, Ebrahim Jafarzadehpour, PhD, Mohamadreza Aghamirsalim, MD,
Mohammad Amin Seyedian, MD, Hassan Hashemi, MD
Contradictory results of postoperative steroid application in pho-
torefractive keratectomy (PRK) led to a meta-analysis of the
existing data to achieve a definite conclusion on the optimum
dosage and duration of corticosteroid therapy after PRK. The
overall pooled unstandardized mean difference (PUMD) of the
corneal haze score was 0.20 (95% CI, 0.29 to 0.12). In
subgroup analysis, the PUMD of the corneal haze score was
statistically significant in 2 subgroups,0.57 (0.85 to0.30) for
3 to 6 months postoperatively and 0.13 (0.23 to 0.04) for ≤
3 months postoperatively. Analysis of the PUMD of postoperative
spherical equivalent in participants with low to moderate myopia
(≥6.00 D) and high myopia (<6.00 D) showed positive effects
of steroids on prevention of myopia regression. In conclusion,
long-term topical steroid application after PRK seems unneces-
sary in low and moderate myopia. New randomized clinical trials
using current technologies are recommended for postoperative
treatments.
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Photorefractive keratectomy (PRK), introduced in1983, was the first refractive surgical technique to beapproved by the U.S. Food and Drug Administration
in 1996.1 Although laser in situ keratomileusis (LASIK)
became popular, PRK is still preferred by many surgeons
because of a lower risk for ectasia, lack of flap complica-
tions, and high predictable results.2 However, subepithelial
corneal haze and refractive error regression due to trans-
formation of keratocytes into myofibroblasts are serious
complications of PRK.3,4 Myofibroblasts produce abnormal
collagens causing corneal haze, light scattering, and decreased
visual acuity.5,6
Corneal haze is often associated with myopic regression,
and its severity depends on a variety of risk factors.7 A higher
depth of ablation is associated with more corneal haze.8 In
addition, the risk for corneal haze and regression increases
with a smaller ablation zone diameter, preoperative astig-
matism more than 1.25 diopter (D), and ultraviolet (UV)
radiation exposure.9–12 A brown iris and a history of refractive
surgery are other risk factors of corneal haze formation.9,13
The corneal inflammatory responses should be mini-
mized by anti-inflammatory agents such as corticosteroids
or nonsteroidal anti-inflammatory drugs to prevent corneal
haze.14 Many surgeons believe that corticosteroids can
reduce corneal opacity and modulate postoperative myopic
regression.15,16 On the other hand, some studies reject the
effectiveness of corticosteroids on corneal haze and con-
sider the role of topical steroids on myopic regression only
during their application.17,18
Steroids for 3 months postoperatively have been pre-
scribed since the introduction of PRK, but long-term ste-
roid therapy can result in side effects, such as increased
intraocular pressure, glaucoma, cataract, delayed epithelial
healing, and increased risk for corneal infection.19,20
Mitomycin C has been used in refractive surgery since
1997, and its efficacy in inhibiting corneal haze formation
and modulating the postoperative corneal healing is con-
firmed in animal studies.21–24
Although corticosteroids are administered routinely after
PRK, studies have controversial results and suggestions.
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Caubet found that corticosteroids could prevent corneal haze
after PRK, whereas O’Brart et al. concluded that steroids had
no effect on corneal haze and visual efficiency after PRK, and
therefore long-term steroid application is not necessary.16,18
In a review article, Corbett et al. found no justification for
prescribing corticosteroids after PRK, at least for low or
moderate myopia.25 Although topical steroids are routinely
used for 3 months after PRK, there is no solid consensus
about the dosage and duration of steroid administration.
Moreover, it is commonly seen that corneal haze does not
develop in some patients who undergo PRK and do not
adhere to their 3-month duration of steroid regimen.
Application ofmitomycinC and improvements to instrument
function with smaller laser spot size have resulted in a smoother
corneal surface and less corneal haze. Therefore, long-term
corticosteroid application may not be necessary after PRK.
These contradictory results led us to perform a systematic
review of the existing data to attain a conclusion about the
optimum dosage and duration of corticosteroid therapy
after PRK.
METHODS
This study was registered in the International Prospective Register
of Systematic Reviews (PROSPERO) (CRD42018102337) avail-
able online at: http://www.crd.york.ac.uk/PROSPERO/dis-
play_record.php?ID=CRD42018102337. All stages of this meta-
analysis were performed based on the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses guidelines (PICOTS).26
Search Strategy
The following databases were searched without any language or
location restrictions between January 1, 1980, and February 15, 2019:
PubMed, Scopus,Web of Sciences, EMBASE, and Cochrane Library.
An extensive search was performed using MeSH (Medical Subject
Headings) terms and text words to find the studies related to
corticosteroid use in PRK surgery. Figure 1 shows the search strategy
prepared for MEDLINE, which was then used in other databases.
Inclusion and Exclusion Criteria
The PICOTS (population, intervention, comparison, outcome,
time, study design) criteria were: (1) population: refractive surgery
candidates aged 18 years or older who underwent PRK, laser
subepithelial keratomileusis, or epi–LASIK without a history of
ocular surgery; (2) intervention: eyes treated with corticosteroids;
(3) comparison: placebo, nothing, or nonsteroidal anti-
inflammatory medicine as postoperative treatment, with or with-
out the use of mitomycin; (4) outcome: corneal haze score and
myopic regression; (5) time: January 1, 1980, until January 28, 2018;
(6) study design: all studies were included regardless of their design.
Studies conducted in patients with a history of ocular surgery
were excluded. Animal or laboratory studies, review articles,
letters, editorials, and conference abstracts were also excluded.
Study Selection and Data Extraction
Studies extracted from the databases were entered into EndNote X7
(Clarivate). Duplicates were removed, and then 2 reviewers (M.P.,
M.K.) screened the studies independently to select studies that met
the inclusion criteria in 2 stages: evaluation of studied based on titles
and abstracts and evaluation based on full texts. Any disagreements
were resolved through discussion or a third reviewer. The following
data were extracted: the first author’s name, publication year, study
location, study design, surgery type, ablation diameter, quality
assessment, sample size, steroid duration, group of intervention or
control, preoperative spherical equivalent (SE), follow-up time, and
outcome. The eligible data were entered into Excel files (Microsoft).
The kappa coefficient between the 2 reviewers was 89%. Blinding
and task separation was used in the study selection procedure.
Assessment of Study Quality
Quality assessment was performed using the Consolidated
Standards of Reporting Trials (CONSORT) checklist for clinical
trials and Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE) for observational studies. Each item in
these checklists received a score of 1, and the final score was
calculated in percent. The results were categorized into 4 groups:
very low quality (less than 20%), low quality (20% to 40%),
moderate quality (40% to 60%), high quality (60% to 80%), and
very high quality (more than 80%). Low-quality studies were
excluded from the meta-analysis.27,28
Figure 1. Search strategy based on PICOTS for
MEDLINE (Epi-LASIK = epi–laser in situ kera-
tomileusis; MeSH = Medical Subject Headings).
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Outcomes
The outcomes were mean corneal haze score and postoperative
mean SE. The postoperative steroid duration was evaluation of the
corneal haze score and postoperative SE was performed in 2 cat-
egories as follows: (1) steroid duration <3 months (months post-
operatively) and (2) steroid duration ≥ 3 months. The time of
outcome measurement was classified into 4 groups, including
(1) follow-up ≤ 3 months; (2) follow-up > 3 to ≤ 6 months;
(3) follow-up > 6 to ≤ 12 months, and (4) follow-up > 12 months.
The preoperative SE was evaluated in 2 groups as follows: (1) pre-
operative SE ≥ 6.00 D and (2) preoperative SE < 6.00 D.
Statistical Methods and Assessment of Heterogeneity
All analyses were performed using STATA, version 14.0. For each
study, the sample size and the mean and steroid duration of
corneal haze and SE were extracted in the control and intervention
groups before refractive surgery and during postoperative follow-
ups. The data of corneal haze and SE were extracted from figures
in some studies.29–31
The mean difference was calculated to determine the difference
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The Cochran Q test of heterogeneity was used to determine
heterogeneity, and its amount was calculated by I2 statistic. I2 > 70%
was considered high heterogeneity based on the Higgins classifi-
cation. A fixed-effect model was used to estimate the pooled mean
difference (a random-effect model was used if I2 > 70%). Because of
the similar outcome units in the control and intervention groups, we
used the pooled unstandardized mean difference (PUMD) in this
meta-analysis. Ultimately, a meta-regression model was applied to
evaluate the effect of age, SE, study design, sample size, publication
year, study quality, and ablation diameter on heterogeneity between
studies for haze and postoperative SE. The significance level was set
at .05 in all analyses.
RESULTS
Study Selection
Of 1262 records identified in electronic databases between
January 1, 1980, and February 15, 2019, 320 studies were
excluded because of duplication. Then, the titles and ab-
stracts of the remaining 942 studies were read, resulting in
exclusion of 863 irrelevant records. After reading the full
texts of 79 studies, 68 articles were excluded because they
did not meet the eligibility criteria for the review. One study
was excluded despite having inclusion criteria because it
was impossible to calculate the pooled SE.18 Two other
studies were also excluded because of their low quality.27,28
Eventually, 7 studies were included in meta-analysis.
Corneal haze and SE were assessed in 6 and 5 studies,
respectively (Figure 2).29–35
Study Characteristics
Two studies contained more than 1 study with different
designs in each.29,34 Two studies were published by
Baek et al. in 1997. The preoperative SE was referred to
as Baek (1997)-1, and the second was referred to as Baek
(1997)-2.29,30 Baek (1997)-1 consisted of 2 studies: Baek
(1997)- 1(A) and Baek (1997)- 1(B). Baek (1997)-2 had 2
control groups referred to as Baek (1997)-2 (Crt1) and Baek
(1997)-2 (Crt2). In 1994, Fagerholm et al. published a study
consisting of 3 studies: Fagerholm (1994); (A), Fagerholm
(1994); (B), and Fagerholm (1994); (C).34 Fagerholm (1994);
(C) had 2 intervention groups: Fagerholm (1994); C (Int1)
and Fagerholm (1994); C (Int2) in which steroids were
prescribed for 5 weeks and 3 months, respectively.
Supplemental Table 1 (see Supplemental Digital Content,
http://links.lww.com/JRS/A30) shows the details of the
studies. Six of the 7 studies (Aras et al., Badala et al., Baek
(1997)- 1(A), Baek (1997)- 2, Gambato et al., and Gartry
et al.) had an RCT design, and 4 (Baek (1997)- 1(B), Fa-
gerholm (1994); (A), Fagerholm (1994); (B), and Fagerholm
(1994) (C)); had a historical cohort design.29,30,32–35
The maximum (2.33) and minimum (0) corneal haze
scores were reported in control groups 4 and 12 months
postoperatively, respectively.30,35 The maximum (+2.39 D)
and the minimum postoperative SEs (3.00 D) were re-
ported in control groups 3 weeks and 6 months post-
operatively, respectively.30,33
Corneal Haze Score
The corneal haze score was graded from 0 to 4 in studies,
with 0 indicating no haze and 4 representing maximum
opacity. According to the meta-analysis, the overall
PUMD of the corneal haze score was 0.20 (95%
CI, 0.29 to 0.12), indicating a statistically significant
difference between the steroid and nonsteroid groups in
favor of the steroid group. Subgroup analysis showed
Figure 2. Flowchart of the study selection process.
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a lower mean haze score at least 6 months post-
operatively in patients who received steroids for at least
3 months postoperatively, although this finding was not
statistically significant. Figure 3 demonstrates the
PUMD of the haze score in different steroid duration
and follow-up subgroups.
Figure 3. PUMD of the haze score based on the random-effects model in different steroid duration and measurement time groups. The
midpoint of each line segment shows the estimate, the length of the line segment indicates the 95%CI in each study, and the diamond mark
illustrates the PUMD of the haze score (F/U = follow-up; PUMD = pooled unstandardized mean difference; SD = steroid duration; months =
months postoperatively).
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The mean difference of the haze score (intervention
minus control) was statistically significant in 2 subgroups,
0.57 (0.85 to0.30) for steroid duration ≥ 3 and follow-
up > 3 to ≤ 6 months and 0.13 (0.23 to 0.04) for
steroid duration ≥ 3 and follow-up ≤ 3 months. The dif-
ference was not significant in other subgroups. Analysis of
corneal haze based on preoperative SE showed a significant
difference in both subgroups of ≥6 D and <6 D, which
was higher in <6 D. The PUMD of the haze score
was 0.18 (0.25 to 0.11) and 0.39 (0.61 to 0.17)
in ≥6 D and <6 D, respectively (Figure 4).
Estimate of Postoperative Spherical Equivalent
The overall PUMD of postoperative SE between the steroid
and control groups (interventionminus control) was estimated
at 0.43 (95%CI, 0.21 to 0.66), indicating the effect of steroid on
prevention ofmyopic regression. Figure 5 shows the PUMDof
postoperative SE in different steroid duration and follow-up
subgroups. The difference was above zero in subgroups of
steroid duration ≥ 3; follow-up ≤ 6 months and steroid du-
ration < 3; and follow-up > 6 months, indicating the positive
effect of steroids on postoperative SE (0.52 [0.27 to 0.77] and
0.46 [0.01 to 0.91], respectively). No significant difference was
observed in the other subgroup (steroid duration ≥ 3; follow-
up > 6 months).
Analysis of the PUMD of postoperative SE in participants
with low (≥6 D) to moderate myopia (<6 D) showed
positive effects of steroids on prevention of myopia re-
gression (0.40 [0.19 to 0.61] and 0.97 [0.43 to 1.52], re-
spectively) (Figure 6). All subgroup analyses are presented
in Figure 7.
Heterogeneity and Meta-regression
According to meta-regression results, the following
variables had significant effects on heterogeneity in the
mean difference of the haze score between studies: study
Figure 4. Pooled un-
standardized mean differ-
ence of the haze score
based on the random-ef-
fects model in different
subgroups of preoperative
SE (SE = spherical
equivalent).
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design (0.364; P = .001), study quality (0.033; P = .040), and
total sample size (0.004; P < .001). In other words, the mean
difference of the haze score was higher in historical cohorts
and higher quality studies with larger sample sizes. Het-
erogeneity in postoperative SEwas due to some variables such
as quality (0.084; P = .001) and total sample size (0.005;
P < .017). Publication year (0.105; P = .045) and ablation
diameter (0.153; P = .048) also had a borderline significant
effect. Newer studies, high-quality studies, and studies with
larger sample sizes and ablation diameters reported lower
myopic regression postoperatively (Tables 1 and 2). The
effect of sample size on the haze score and postoperative
mean difference is demonstrated in Figures 8 and 9,
respectively.
DISCUSSION
Corneal haze is one of the most feared complications of PRK
surgery, which develops because of the normal wound healing
Figure 5. PUMD of postoperative SE based on the random-effects model in different steroid duration and measurement time groups. The
midpoint of each line segment shows the estimate, the length of the line segment indicates the 95%CI in each study, and the diamond mark
illustrates the PUMD of postoperative SE (PUMD = pooled unstandardized mean difference; SD = steroid duration; SE = spherical equivalent;
months = months postoperatively).
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process. After epithelial injury and basement membrane
destruction, inflammatory mediators such as cytokines and
growth factors are released from epithelial cells that activate
differentiation of keratocytes into myofibroblasts. Myofi-
broblasts express different extracellular matrix. Disorganized
matrix material including abnormal collagen fibers and other
substances remodels the stromal tissue, which is associated
with decreased corneal transparency and corneal haze
development.36–40 Corticosteroids are anti-inflammatory
agents that maintain the transparency of the cornea
through inhibition of the immune response and collagen
synthesis. Corticosteroids are applied postoperatively to avoid
corneal haze and myopic regression after PRK.
This meta-analysis evaluated the effect of steroid ad-
ministration on the postoperative corneal haze score and
SE after refractive surgical procedures such as PRK and
laser subepithelial keratomileusis. The overall results
suggested that steroid administration resulted in lower
Figure 6. Pooled unstandardized mean difference of postoperative SE based on the random-effects model in different subgroups of
preoperative SE (SE = spherical equivalent).
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haze scores, but interpretation of the results could be
influenced by several factors such as lack of available
studies in this area.
There are 2 types of corneal haze after refractive surgery.
The first type occurs 1 to 3months postoperatively and lasts
for 12 months. The other type, with a late onset, develops
between 2 and 5 months postoperatively and may persist
for 3 years.14 As shown in Figure 3, only 6 studies reported
the data of haze and entered the meta-analysis, of which
only 3 provided the results of the 12-month follow-up.
However, the results of follow-up for more than 3 months
postoperatively showed no significant difference between
the steroid and control groups. Similarly, although the
overall postoperative myopic regression was higher in
control groups compared with steroid groups, it was limited
to 6-month follow-ups.
Figure 7. PUMD in different
subgroups based on the
random-effects model. Di-
amond mark illustrates the
PUMD (PUMD = pooled
unstandardized mean
difference).
Table 1. Results of univariate meta-regression analysis on the heterogeneity of the determinants for the unstandardized
mean difference of the haze score.
Variable Coefficient 95% CI P Value
Age, y 0.005 0.024 to 0.035 .717
Spherical equivalent, D 0.157 0.412 to 0.097 .220
Design 0.364 0.149 to 0.580 .001*
Publication year 0.038 0.002 to 0.079 .064
Ablation diameter 0.055 0.004 to 0.115 .067
Quality assessment 0.033 0.001 to 0.065 .040*
Total sample size 0.004 0.002 to 0.006 .000*
Ablation diameter: 1 = 4.0 mm; 2 = 5.0 mm; 3 = 6.0 mm; 4 = 6.0 to 9.0 mm; 5 = 7.0 mm
SE: 1 ≤ 6 D; 2 > 6 D.
Design: 1 = RCT; 2 = historical cohort.
Quality assessment: score.
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Most of the studies were published at least 20 years ago
and did not apply mitomycin during the procedure. Mi-
tomycin C, as a genotoxic antibiotic, inhibits cell mitosis
and protein synthesis through blocking the synthesis of
DNA. This antibiotic can reduce PRK complications asso-
ciated with haze and refractive error regression via obstructing
the transformation of keratocytes into myofibroblasts.24,41,42
Meta-regression results also proved the effect of publication
year. Smaller differences in myopic regression were observed
between groups in newer studies (β = 0.105; P = .045).
The design of the studies included in this meta-
analysis as another factor affecting the results. The
study design was one of the sources of heterogeneity in
the mean corneal haze score between the steroid and
control groups (β = 0.364; P = .001). In other words,
steroid administration was more effective in studies
with a historical cohort design than RCTs. Randomi-
zation and blinding, which enhance the study results,
are not used in cohort designs.
A small ablation diameter is a known risk factor for
corneal haze development in some studies.9,10 The results of
this meta-analysis showed that a larger ablation diameter
could increase the SE difference between groups; in other
words, in larger ablation diameters, the role of steroids
could be weaker in prevention of postoperative haze.
High myopic ablations (higher ablation depth) generate
more myofibroblasts than low to moderate myopic abla-
tions; therefore, they could result in more postoperative
haze and myopic regression.43,44 The results of our study
confirmed that steroids were more effective in higher
myopic ablations (more than 6 D).
Corneal haze formation was more probable with early
excimer laser instruments. Recent generations with small
beams provide more uniform corneal profiles and decrease
the release of proinflammatory cytokine, which leads to
better visual outcomes and sooner refractive stability.45–47
Broad beam lasers were used in most of the included studies
in this meta-analysis, which belong to the older generations,
and only 2 studies applied flying spot systems. Because of
the limited number and variety of these studies, we could
not investigate the effect of the type of excimer machine on
corneal haze development.
UV radiation exposure has been reported as a risk factor
for haze formation after surface ablation.12,48 Exposure to
UV radiation is very high in some places such as tropical
Figure 8. Results of meta-regression on the relationship between
the unstandardized mean difference of the haze score and the total
sample size. Circle size represents the precision of each study.
There is no significant relationship between the unstandardized
mean difference of the haze score and the total sample size.
Figure 9. Results of meta-regression on the relationship between
the unstandardized mean difference of postoperative SE and the
total sample size. Circle size represents the precision of each study.
There is a significant relationship between the unstandardizedmean
difference of postoperative SE and the total sample size. The mean
difference of postoperative SE relatively decreased with the in-
crease in the sample size (SE= spherical equivalent).
Table 2. Results of univariate meta-regression analysis on the heterogeneity of the determinants for the unstandardized
mean difference of postoperative SE.
Variable Coefficient 95% CI P Value
Age, y 0.049 0.063 to 0.163 .383
SE, D† 0.503 0.040 to 1.048 .069
Design 0.133 0.462 to 0.196 .421
Publication year 0.105 0.208 to 0.002 .045*
Ablation diameter 0.153 0.306 to 0.001 .048*
Quality assessment, score 0.084 0.134 to 0.035 .001*
Total sample size 0.005 0.009 to 0.000 .017*
RCT = randomized clinical trial; SE = spherical equivalent
Ablation diameter: 1 = 4.3 mm; 2 = 5.0 mm; 3 = 6.0 mm; 4 = 7.0 mm.
Design: 1 = RCT; 2 = historical cohort.
†SE: 1 ≤ 6 D; 2 > 6 D.
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countries. However, studies included in this meta-analysis
were conducted in Asian and European countries, and
geographical location was not statistically significant in
meta-regression analysis.
The most important limitation of this meta-analysis was
scares of the relevant studies, especially RCTs, having both
steroid and control groups. Another limitation was lack of
high-quality and new articles that made a robust conclusion
impossible. Some of these few available studies reported
their data only by figures that were inappropriate data to
analyze. Finally, most of the studies reported the 6-month
follow-up results, and few of them followed their patients
until 12 months.
In conclusion, the results of this systematic review and
meta-analysis suggest that steroids can reduce post-
operative corneal haze and myopic regression during the
first 6 months after refractive surgery, but the results are
similar in long-term follow-up studies. Long duration post-
refractive surgery steroid administration seems to be un-
necessary in low and moderate myopia compared with high
myopia. A randomized clinical trial with advanced and
newer machines might clarify the optimum duration of
postoperative steroids more precisely.
WHAT WAS KNOWN
 Topical steroids are administered routinely after photo-
refractive keratectomy from weeks to months to prevent
corneal haze and myopic regression.
WHAT THIS PAPER ADDS
 Steroids can reduce postoperative corneal haze and myopic
regression during the first 6 months after refractive surgery,
but the results are similar in long-term follow-ups.
 Long duration post-refractive surgery steroid administration
seems to be unnecessary in low and moderate myopia
compared with high myopia.
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